BIOCRYST PHARMACEUTICALS INC (BCRX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-15

BIOCRYST PHARMACEUTICALS INC (BCRX) has filed 16 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-15. 4 Form 8-K material event filings were reported by BCRX in the last 90 days. 2 Form 144 notices of proposed sale were filed for BCRX stock. InsiderAlpha tracks every BCRX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About BIOCRYST PHARMACEUTICALS INC (BCRX)

SEC CIK0000882796

90-Day SEC Filing Activity

Form 4 filings (90d)16
Form 8-K filings (90d)4
Form 144 notices (90d)2
Latest Form 4 filing2026-06-15

Recent BCRX Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
HEGGIE THERESADirectorA — Grant or award15.3K$0.00—SEC
Stonehouse Jon PDirectorA — Grant or award15.3K$0.00—SEC
LEVIN ALAN GDirectorA — Grant or award15.3K$0.00—SEC
McKee Amy EDirectorA — Grant or award15.3K$0.00—SEC
Galson Steven KDirectorA — Grant or award15.3K$0.00—SEC
Milne Jill C.DirectorA — Grant or award15.3K$0.00—SEC
Frank StevenDirectorA — Grant or award15.3K$0.00—SEC
SANDERS MACHELLEDirectorA — Grant or award15.3K$0.00—SEC
MILANO VINCENTDirectorA — Grant or award15.3K$0.00—SEC
Stonehouse Jon PDirectorA — Grant or award631$8.91$6KSEC
MILANO VINCENTDirectorA — Grant or award1.1K$8.91$10KSEC
Frank StevenDirectorA — Grant or award1.3K$8.91$11KSEC
McKee Amy EDirectorA — Grant or award631$8.91$6KSEC
Milne Jill C.DirectorA — Grant or award1.3K$8.91$11KSEC
McKee Amy EDirectorS — Open-market sale11.2K$8.97$100KSEC

All transactions sourced from SEC EDGAR Form 4 filings for BIOCRYST PHARMACEUTICALS INC (BCRX). Updated in real time as new filings are submitted to the SEC.

Most-Active BCRX Insiders — Last 90 Days

InsiderForm 4 filingsTotal transaction value
McKee Amy E4$106K
Frank Steven3$11K
MILANO VINCENT3$10K
Stonehouse Jon P3$6K
Barnes Alane P3$911K

Recent BCRX Form 8-K Material Events

Recent BCRX Form 144 Notices of Proposed Sale

Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in BCRX insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

BCRX Insider Trading — FAQ

What is the latest insider trade for BCRX?
BIOCRYST PHARMACEUTICALS INC (BCRX) had 16 insider filings in the last 90 days, with the most recent on 2026-06-15. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying BCRX stock?
0 insider purchases of BCRX were filed in the last 90 days.
How many insiders are selling BCRX stock?
0 insider sales of BCRX were filed in the last 90 days.
Where can I see BCRX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every BCRX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live BCRX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.